Correlation Between Pfizer and SEB SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and SEB SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and SEB SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and SEB SA, you can compare the effects of market volatilities on Pfizer and SEB SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of SEB SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and SEB SA.

Diversification Opportunities for Pfizer and SEB SA

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and SEB is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and SEB SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SEB SA and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with SEB SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SEB SA has no effect on the direction of Pfizer i.e., Pfizer and SEB SA go up and down completely randomly.

Pair Corralation between Pfizer and SEB SA

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the SEB SA. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.57 times less risky than SEB SA. The stock trades about -0.08 of its potential returns per unit of risk. The SEB SA is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1,033  in SEB SA on September 3, 2024 and sell it today you would earn a total of  169.00  from holding SEB SA or generate 16.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  SEB SA

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
SEB SA 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SEB SA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, SEB SA showed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and SEB SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and SEB SA

The main advantage of trading using opposite Pfizer and SEB SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, SEB SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SEB SA will offset losses from the drop in SEB SA's long position.
The idea behind Pfizer Inc and SEB SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments